These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 25698514)

  • 1. Two thiazolylindoles and a benzimidazole: novel compounds on the designer drug market with potential cannabinoid receptor activity.
    Westphal F; Sönnichsen FD; Knecht S; Auwärter V; Huppertz L
    Forensic Sci Int; 2015 Apr; 249():133-47. PubMed ID: 25698514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural characterization and pharmacological evaluation of the new synthetic cannabinoid CUMYL-PEGACLONE.
    Angerer V; Mogler L; Steitz JP; Bisel P; Hess C; Schoeder CT; Müller CE; Huppertz LM; Westphal F; Schäper J; Auwärter V
    Drug Test Anal; 2018 Mar; 10(3):597-603. PubMed ID: 28670781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel cannabimimetic phenylacetylindole, cannabipiperidiethanone, as a designer drug in a herbal product and its affinity for cannabinoid CB₁ and CB₂ receptors.
    Uchiyama N; Kikura-Hanajiri R; Goda Y
    Chem Pharm Bull (Tokyo); 2011; 59(9):1203-5. PubMed ID: 21881274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of designer drugs: synthesis and spectroscopic analysis of synthetic cannabinoid analogues of 1H-indol-3-yl(2,2,3,3-tetramethylcyclopropyl)methanone and 1H-indol-3-yl(adamantan-1-yl)methanone.
    Carlsson A; Lindberg S; Wu X; Dunne S; Josefsson M; Åstot C; Dahlén J
    Drug Test Anal; 2016 Oct; 8(10):1015-1029. PubMed ID: 26526273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CBL-2201. Report on a new designer drug: Napht-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate.
    Kondrasenko AA; Goncharov EV; Dugaev KP; Rubaylo AI
    Forensic Sci Int; 2015 Dec; 257():209-213. PubMed ID: 26386336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1H-Benzimidazole derivatives as mammalian DNA topoisomerase I inhibitors.
    Alpan AS; Gunes HS; Topcu Z
    Acta Biochim Pol; 2007; 54(3):561-5. PubMed ID: 17823665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-Naphthoylindazoles and 2-naphthoylbenzoimidazoles as novel chemical groups of synthetic cannabinoids: chemical structure elucidation, analytical characteristics and identification of the first representatives in smoke mixtures.
    Shevyrin V; Melkozerov V; Nevero A; Eltsov O; Morzherin Y; Shafran Y
    Forensic Sci Int; 2014 Sep; 242():72-80. PubMed ID: 25036783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the novel synthetic cannabimimetic 8-quinolinyl 4-methyl-3-(1-piperidinylsulfonyl)benzoate (QMPSB) and other designer drugs in herbal incense.
    Blakey K; Boyd S; Atkinson S; Wolf J; Slottje PM; Goodchild K; McGowan J
    Forensic Sci Int; 2016 Mar; 260():40-53. PubMed ID: 26795397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel benzimidazole derivatives as selective CB2 agonists.
    Pagé D; Balaux E; Boisvert L; Liu Z; Milburn C; Tremblay M; Wei Z; Woo S; Luo X; Cheng YX; Yang H; Srivastava S; Zhou F; Brown W; Tomaszewski M; Walpole C; Hodzic L; St-Onge S; Godbout C; Salois D; Payza K
    Bioorg Med Chem Lett; 2008 Jul; 18(13):3695-700. PubMed ID: 18522867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UR-144 in products sold via the Internet: identification of related compounds and characterization of pyrolysis products.
    Kavanagh P; Grigoryev A; Savchuk S; Mikhura I; Formanovsky A
    Drug Test Anal; 2013 Aug; 5(8):683-92. PubMed ID: 23315949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure elucidation of a new designer benzylpiperazine: 4-bromo-2,5-dimethoxybenzylpiperazine.
    Westphal F; Junge T; Girreser U; Stobbe S; Pérez SB
    Forensic Sci Int; 2009 May; 187(1-3):87-96. PubMed ID: 19345524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic cannabinoids as designer drugs: new representatives of indol-3-carboxylates series and indazole-3-carboxylates as novel group of cannabinoids. Identification and analytical data.
    Shevyrin V; Melkozerov V; Nevero A; Eltsov O; Baranovsky A; Shafran Y
    Forensic Sci Int; 2014 Nov; 244():263-75. PubMed ID: 25305529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3D-QSAR studies of arylpyrazole antagonists of cannabinoid receptor subtypes CB1 and CB2. A combined NMR and CoMFA approach.
    Chen JZ; Han XW; Liu Q; Makriyannis A; Wang J; Xie XQ
    J Med Chem; 2006 Jan; 49(2):625-36. PubMed ID: 16420048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analytical characterization of four new ortho-methoxybenzylated amphetamine-type designer drugs.
    Westphal F; Girreser U; Waldmüller D
    Drug Test Anal; 2016 Sep; 8(9):910-9. PubMed ID: 26606897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure elucidation of the designer drug N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-3-(4-fluorophenyl)-pyrazole-5-carboxamide and the relevance of predicted (13) C NMR shifts - a case study.
    Girreser U; Rösner P; Vasilev A
    Drug Test Anal; 2016 Jul; 8(7):668-75. PubMed ID: 26012418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isomeric fluoro-methoxy-phenylalkylamines: a new series of controlled-substance analogues (designer drugs).
    Rösner P; Quednow B; Girreser U; Junge T
    Forensic Sci Int; 2005 Mar; 148(2-3):143-56. PubMed ID: 15639609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and structural elucidation of four cannabimimetic compounds (RCS-4, AM-2201, JWH-203 and JWH-210) in seized products.
    Denooz R; Vanheugen JC; Frederich M; de Tullio P; Charlier C
    J Anal Toxicol; 2013 Mar; 37(2):56-63. PubMed ID: 23339188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of the designer drug and synthetic cannabinoid receptor agonist AM-2201 regarding its chemistry and metabolism.
    Hutter M; Moosmann B; Kneisel S; Auwärter V
    J Mass Spectrom; 2013 Jul; 48(7):885-94. PubMed ID: 23832945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and analytical characterization of four synthetic cannabinoids ADB-BICA, NNL-1, NNL-2, and PPA(N)-2201.
    Qian Z; Jia W; Li T; Hua Z; Liu C
    Drug Test Anal; 2017 Jan; 9(1):51-60. PubMed ID: 27239006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Four types of cannabimimetic indazole and indole derivatives, ADB-BINACA, AB-FUBICA, ADB-FUBICA, and AB-BICA, identified as new psychoactive substances.
    Qian Z; Hua Z; Liu C; Jia W
    Forensic Toxicol; 2016; 34():133-143. PubMed ID: 26793280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.